Monday, November 25, 2024

VA Sources Sought: PVAHCS Clinical Surveillance Tool

Notice ID: 36C25821Q0202

“The Phoenix VAMC Pharmacy requires a comprehensive patient clinical surveillance, monitoring and intervention software program that provides clinical staff immediate, real-time lists of patients, identifies those who need clinical intervention based on current best practice guidelines and facility determined criteria and provides the ability of clinical staff to monitor and protect patients from drug interactions and adverse events.”

“The program must have the capability of targeting only those patients who need clinical interventions, resulting in increased resourcing of staff. The software program will also need to allow Pharmacy and facility to meet regulatory requirements set by Joint Commission Standards, National Patient Safety Goals as part of the Joint Commission requirements and VHA directives.”

“The software solution needs to provide clinical staff antimicrobial stewardship which will directly assist the facility in meeting its Directive 1031, Antimicrobial Stewardship Programs (ASP) dated January 30, 2019 delineating VA Medical Center’s responsibilities with antimicrobial stewardship. The software maintenance and support program will need to include security patches and software updates, and 24/7 technical support, including telephone support.”

“Technical Requirements:

  • The clinical surveillance, monitoring and intervention software program must provide a documentation tool which allows users to record and track clinical activities and interventions performed during patient care.
  • The clinical software program must have the capability of notifying clinicians in real-time when specific clinical criteria have occurred. Three alert groups used most often must include Renal Function alerts, Therapeutic Antibiotic Monitoring alerts, and defined alerts based on local initiatives).
  • The clinical software program must provide flagging tools allowing patients to be prioritized for follow-up or action.
  • The clinical software should allow users to create a “rounding view” or profile for each patient containing relevant, user-selected criteria.
  • The clinical surveillance software must have the capability of allowing users to survey, document, and report infections at a facility. Tools such as flags and alerts working in conjunction with actionable information to assist with patient care decisions should be available to the provider. Problematic infection types frequently surveyed should include those associated with Central Line Associated Bloodstream Infections (CLABSI), Catheter Associated Urinary Tract Infections (CAUTI), and C. difficile infections (CDI)…”

Read more here.

[related-post]

LEAVE A REPLY

Please enter your comment!
Please enter your name here

FedHealthIT Xtra – Find Out More!

Recent News

Don’t Miss A Thing

Jackie Gilbert
Jackie Gilbert
Jackie Gilbert is a Content Analyst for FedHealthIT and Author of 'Anything but COVID-19' on the Daily Take Newsletter for G2Xchange Health and FedCiv.

Subscribe to our mailing list

* indicates required